Ginkgo biloba pretreatment partially protects from the dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium.
Rojas
P
P
Laboratory of Neurotoxicology, Instituto Nacional de Neurología y Neurocirugía, México, D.F., México.
Rojas-Castañeda
J
J
Vigueras
R M
RM
Rojas
C
C
D015655:1-Methyl-4-phenylpyridinium / Q000633:toxicity*; D000818:Animals; D003342:Corpus Striatum / Q000473:pathology; D004298:Dopamine / Q000502:physiology*; D005419:Flavonoids / Q000494:pharmacology*; D020441:Ginkgo biloba; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018696:Neuroprotective Agents / Q000494:pharmacology*; D020258:Neurotoxicity Syndromes / Q000517:prevention & control*; D018384:Oxidative Stress / Q000502:physiology; D010936:Plant Extracts; D010946:Plants, Medicinal; D000096983:Ginkgo Extract
D015655:1-Methyl-4-phenylpyridinium; D004298:Dopamine; D005419:Flavonoids; D018696:Neuroprotective Agents; D010936:Plant Extracts; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract